News
PPBT
3.420
-0.87%
-0.030
Weekly Report: what happened at PPBT last week (1209-1213)?
Weekly Report · 12/16 09:45
Weekly Report: what happened at PPBT last week (1202-1206)?
Weekly Report · 12/09 09:43
Purple Biotech Advances Oncology Drugs with New Funding
TipRanks · 12/06 12:58
Purple Biotech Ltd. Closes $2.8 Million Registered Direct Offering of American Depositary Shares
Barchart · 12/05 16:32
Purple Biotech Secures $2.8 Million for Oncology Advancements
TipRanks · 12/05 12:47
Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary Shares
Barchart · 12/05 06:13
News Movers: Yesterday’s Hottest News That Could Move the Needle Today
Barchart · 12/05 01:38
Purple Biotech Signs Securities Purchase Agreement
TipRanks · 12/04 16:58
Purple Biotech Secures $2.8 Million Through ADS Offering
TipRanks · 12/03 21:36
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 12/03 21:05
Purple Biotech Ltd. Announces $2.8 Million Registered Direct Offering of American Depositary Shares
Barchart · 12/03 17:36
Why Purple Biotech (PPBT) Stock Is Getting Hammered
Benzinga · 12/03 14:30
Purple Biotech shares fall on $2.8M direct offering of ADS
Seeking Alpha · 12/03 14:02
Purple Biotech to sell 472,668 ADSs at $6.00 in registered direct offering
TipRanks · 12/03 13:25
Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares
Barchart · 12/03 07:23
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 12/02 21:05
News Movers: Today’s Hottest News That Could Move the Needle Tomorrow
Barchart · 12/02 19:44
Why Is Purple Biotech Stock Trading Higher On Monday?
Benzinga · 12/02 14:18
Purple Biotech soars on positive results from mid-stage trial of its pancreatic cancer treatment
Seeking Alpha · 12/02 13:58
Purple Biotech’s CM24 Shows Promising Cancer Results
TipRanks · 12/02 12:27
More
Webull provides a variety of real-time PPBT stock news. You can receive the latest news about Purple Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.